Cargando…
Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways
Radiotherapy is one of the most common treatment options for local or regional advanced prostate cancer (PCa). Importantly, PCa is prone to radioresistance and often develops into malignancies after long-term radiotherapy. Antrocin, a sesquiterpene lactone isolated from Antrodia cinnamomea, possesse...
Autores principales: | Chen, Yu-An, Tzeng, David T. W., Huang, Yi-Ping, Lin, Chun-Jung, Lo, U-Ging, Wu, Chia-Lin, Lin, Ho, Hsieh, Jer-Tsong, Tang, Chih-Hsin, Lai, Chih-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356781/ https://www.ncbi.nlm.nih.gov/pubmed/30602706 http://dx.doi.org/10.3390/cancers11010034 |
Ejemplares similares
-
Bacterial Genotoxin-Coated Nanoparticles for Radiotherapy Sensitization in Prostate Cancer
por: Chen, Yu-An, et al.
Publicado: (2021) -
Anti-Oxidant, Anti-Mutagenic Activity and Safety Evaluation of Antrocin
por: Su, Yi-Hui, et al.
Publicado: (2023) -
Sensitization of Radioresistant Prostate Cancer Cells by Resveratrol Isolated from Arachis hypogaea Stems
por: Chen, Yu-An, et al.
Publicado: (2017) -
The regulatory pathways leading to stem-like cells underlie prostate cancer progression
por: Lin, Chun-Jung, et al.
Publicado: (2019) -
Multiomics Identification of Potential Targets for Alzheimer Disease and Antrocin as a Therapeutic Candidate
por: Wu, Alexander T. H., et al.
Publicado: (2021)